STUDY OF ANTI-VIRUS ACTIONS OF METABOLITES OF LACTOBACTERIA
Authors:
- 1 July 2020
- journal article
- research article
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 73 (7) , 1484-1488
Abstract
The aim: of the work was to study the antiviral activity of the metabolites of the probiotic strain Lactobacillus rhamnosus GG (LGG or ATCC 53103) regarding clinical strains of enteroviruses (Coxsackie B-5, ECNO21) isolated from the feces of intestinal infections. Materials and methods: The object of the study was substrate-dependent cell cultures of HeLa, Vero, Hep-2 lines. The titer of the virus was determined by the presence of a clear cytopathic action (CPA) in the monolayer infected cells of the virus. Results: Determination of the enteric virus infections activity in the culture fluid showed that in samples with the LGG metabolites, the infections activity of the clinical strains of enteroviruses decreased after 24 hours, at 1.5-1.7 (p <0.05) times, and after 96 hours in 3, 6 – 5,7 times (p <0,01). the processing of cell cultures by metabolites in the amount of 0.3 mg / ml contributed to a decrease in the titer of viruses by 2.77 ± 0.11 lg TCDD50 / cm3, 2.83 ± 0.11 lg TCD50 / cm3 and 2.94 ± 0.13 lg TCD50 / cm3 for Vero, HeLa and Hep-2 line cells in 24 hours. Conclusions: It has been experimentally determined that the maximum tolerated dose (MTD) of L. rhamnosus GG metabolites was 0.3 μg / ml for all cultures of cell lines. Determination of the antiviral activity of L. rhamnosus GG metabolites in clinical viruses of enteroviruses (Coxsackie B-5 and ECNO-21) showed a decrease in infection activity in 1.5-1.7 times, (p <0.05) of clinical trials in clinical trials enteroviruses.Keywords
This publication has 7 references indexed in Scilit:
- The topical areas of creation and improvement of probiotics (review)Ukrainian biopharmaceutical journal, 2016
- Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteersEuropean Journal of Nutrition, 2013
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- A Strain of Lactobacillus casei Inhibits the Effector Phase of Immune InflammationThe Journal of Immunology, 2011
- Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine productionClinical and Experimental Immunology, 2010
- Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled studyEnvironmental Health, 2005
- Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: A double blind, randomized, controlled trialClinical Nutrition, 2005